AMANDA SACCARO: Open Payments
NPI 1659901353 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,897 in 89 payments from 30 companies in 2025. Trend: 2023 $781 · 2024 $1,303 · 2025 $1,897
Food & beverage: $1,897
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $235 |
| Novartis Pharmaceuticals Corporation | 11 | $234 |
| ABBVIE INC. | 4 | $169 |
| Daiichi Sankyo Inc. | 7 | $154 |
| PFIZER INC. | 8 | $143 |
| Janssen Biotech, Inc. | 7 | $133 |
| Merck Sharp & Dohme LLC | 4 | $97 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| TAIHO ONCOLOGY, INC. | 2 | $56 |
| Eisai Inc. | 3 | $53 |
Products named: EPKINLY, Enhertu, Fabhalta, IMFINZI, KISQALI, DATROWAY, KEYTRUDA, REBLOZYL.
Industry payments across LA — which companies pay providers there.
